![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018 |
Ji Cheol Bae, Lauren A. Beste, Kristina M. Utzschneider |
Endocrinol Metab. 2022;37(3):455-465. Published online June 21, 2022 DOI: https://doi.org/10.3803/EnM.2022.1434 |
The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018 Serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non-alcoholic fatty liver disease Role of Lipid Droplet Proteins in the Development of NAFLD and Hepatic Insulin Resistance Dorothy Hodgkin Lecture 2012* Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management Association Between Non-Invasive Fibrosis Markers and Chronic Kidney Disease Among Adults with Nonalcoholic Fatty Liver Disease in the United States 1012 POST-LOAD INSULIN RESISTANCE IS AN INDEPENDENT PREDICTOR OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 700 Plasma adiponectin in non alcoholic fatty liver disease is related to hepatic insulin resistance and hepatic fat content Determination of metabolic syndrome and insulin resistance rate among adults with ultrasound diagnosed non-alcoholic fatty liver disease Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017–2018 Association between non-invasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease in the United States |